Corcept Therapeutics logo

Associate Director, Medical Writing

Corcept Therapeutics

Redwood City, CAOnsitePosted 47 days ago$189,500 - $223,000
Full TimeDirector & AboveMedical AffairsPharmaceutical
Original posting ↗

Summary

Collaborate with colleagues to write high-quality, strategically aligned medical-writing deliverables supporting the regulatory requirements of a clinical development program, ensuring completeness, accuracy, and compliance with US and ex-US regulatory requirements.

Job description

Responsibilities

  • Author, co-author, critically edit, and format clinical/regulatory documents, including New Drug Applications (NDAs), protocols/protocol amendments, clinical study reports (CSRs), Investigator’s Brochures, and other regulatory submissions as needed
  • Interact with document authors, contributors, and reviewers (including members of Biometrics, Clinical Operations, Clinical Development, Project Management, CMC, Drug Safety, and Regulatory Affairs) to acquire necessary input into documents
  • Develop and manage medical writing timelines for assigned documents to ensure on-time deliverables that meet business needs
  • Lead comment resolution and adjudication with authors, reviewers, and project teams
  • Oversee vendors and contractors
  • May include management of in-house medical writing staff (based on experience and team need)
  • Serve as the functional area representative on project teams and advise such teams on content, format, and style requirements for documents
  • Lead the development/refinement of medical writing processes, SOPs, work instructions, templates, style and content guides, and document quality control to ensure efficient preparation of high-quality medical writing deliverables
  • Maintain subject area expertise related to the company’s investigational products, disease indications, and regulatory and publication guidelines

Preferred Skills, Qualifications and Technical Proficiencies

  • Excellent writing skills coupled with good understanding of the drug development process and relevant regulatory guidelines
  • Ability to write and edit complex material to ensure accuracy, clarity, consistency, and effectiveness
  • Successful track record of working on complex clinical/regulatory writing projects across multiple therapeutic areas
  • Excellent attention to detail, multitasking, prioritization, and flexibility
  • Excellent communication skills with proven ability to interact in a cross-functional environment
  • Understanding of the drug-development process, including research and development processes and objectives and the required documents
  • Familiarity with US and European regulatory requirements and guidelines for documents; general knowledge of electronic Common Technical Document (e-CTD) requirements with respect to structure, format, and content
  • Ability to analyze critically and synthesize complex scientific information from a range of scientific disciplines and clinical therapeutic areas
  • Proficiency in use of MS Office applications (Word, Outlook, Excel, Powerpoint), Adobe Acrobat, electronic document management systems (eg, Veeva Vault, Box, SharePoint), and templates (eg, StartingPoint).
  • Comfortable in a fast-paced small company environment with minimal direction and able to adjust workload based on changing priorities
  • Demonstrated initiative and the ability to manage a variety of projects simultaneously with minimal supervision

Preferred Education and Experience

  • BA/BS degree in a scientific field required; advanced scientific degree (PhD, PharmD, or MS) preferred
  • 7+ years of regulatory medical writing experience in the pharmaceutical industry (or an organization serving them), including experience writing clinical study protocols, clinical study reports, investigator’s brochures, clinical sections of Investigational New Drug (IND) submissions and New Drug Applications (NDAs); and understanding of the content of higher-level summary documents

Requirements

  • BA/BS degree in a scientific field required
  • 7+ years of regulatory medical writing experience in the pharmaceutical industry
  • Experience writing clinical study protocols, clinical study reports, investigator’s brochures, clinical sections of IND submissions and NDAs
  • Understanding of the content of higher-level summary documents
  • Excellent writing skills
  • Good understanding of the drug development process and relevant regulatory guidelines
  • Ability to write and edit complex material
  • Successful track record of working on complex clinical/regulatory writing projects across multiple therapeutic areas
  • Excellent attention to detail, multitasking, prioritization, and flexibility
  • Excellent communication skills with proven ability to interact in a cross-functional environment
  • Familiarity with US and European regulatory requirements and guidelines for documents
  • General knowledge of electronic Common Technical Document (e-CTD) requirements
  • Ability to analyze critically and synthesize complex scientific information
  • Proficiency in MS Office applications (Word, Outlook, Excel, Powerpoint), Adobe Acrobat, electronic document management systems (eg, Veeva Vault, Box, SharePoint), and templates (eg, StartingPoint)
  • Comfortable in a fast-paced small company environment with minimal direction
  • Demonstrated initiative and ability to manage multiple projects simultaneously with minimal supervision

Company overview

Corcept Therapeutics Inc. is a commercial-stage pharmaceutical company founded in 1998 and headquartered in Redwood City, California. The company specializes in the discovery, development, and commercialization of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effects of the hormone cortisol. Corcept's primary focus is on addressing the adverse effects of excess cortisol, which can lead to life-threatening conditions including Cushing's syndrome, various cancers, diabetes, and neurological disorders. The company's flagship product is Korlym (mifepristone), the first FDA-approved oral therapy for treating hyperglycemia in adult patients with endogenous Cushing's syndrome who have type 2 diabetes or glucose intolerance. With approximately 500 employees, Corcept has developed a large portfolio of proprietary compounds that selectively modulate cortisol effects without compromising progesterone function. The company maintains extensive intellectual property covering its selective cortisol modulators and continues to advance clinical trials for potential treatments of hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.